Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Response to mivacurium in patients carrying the k variant in the butyrylcholinesterase gene.

Anesthesiology - 1 Mar 2005

Gätke Mona R, Viby-Mogensen Jørgen, Ostergaard Doris, Bundgaard Jens R

Abstract excerpt

BACKGROUND: Mivacurium is hydrolyzed by the butyrylcholinesterase enzyme, and patients with hereditary changes of the enzyme often have prolonged duration of action of mivacurium. In this study, the authors investigated the significance of the most commonly occurring variant, the Kalow (K) variant, established using DNA analysis, for the response to mivacurium. METHODS: A total of 58 patients carrying either the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Butyrylcholinesterase
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Heterozygote

Share to Isoquinolines

Share to Point Mutation

Source

Identifiers

PMID: 15731585
DOI: 10.1097/00000542-200503000-00005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Response to mivacurium in patients carrying the k variant in the butyrylcholinesterase gene.PMID 15731585Read ↗

Response to succinylcholine in patients carrying the K-variant of the butyrylcholinesterase gene.Semantic proximity Read ↗

Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene: genotyping by sequencing.Semantic proximity Read ↗

Rapid and accurate detection of atypical and Kalow variants in the butyrylcholinesterase gene using denaturing high performance liquid chromatography.Semantic proximity Read ↗

Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA).Semantic proximity Read ↗

Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant: effect of injection of human cholinesterase.Semantic proximity Read ↗

Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase.Semantic proximity Read ↗

Pharmacogenetics and Anaesthesiology.Semantic proximity Read ↗

Markedly prolonged paralysis after mivacurium in a patient apparently heterozygous for the atypical and usual pseudocholinesterase alleles by conventional biochemical testing.Semantic proximity Read ↗

Genetic mutations associated with susceptibility to perioperative complications in a longitudinal biorepository with integrated genomic and electronic health records.Semantic proximity Read ↗

Screening patients with prolonged neuromuscular blockade after succinylcholine and mivacurium.Semantic proximity Read ↗

Prolonged mivacurium neuromuscular block in children.Semantic proximity Read ↗

Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.